To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer ...

Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

The drug is – an oral spray containing ... one of the first additions to NHS treatment for glioblastoma patients since temozolomide chemotherapy in 2007. At the moment Jazz is directed its ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

El-Deiry, have shown that combining a new class of drugs called imipridones with standard glioblastoma treatments ... radiation therapy and the chemotherapy drug temozolomide (TMZ), a regimen ...

Patients treated with Optune in addition to temozolomide survived an additional couple of months compared to those treated with the chemotherapy drug alone. (Glioblastoma patients also undergo ...